Novavax Inc. (NVAX)

$ 8.53
   
  • Change Today:
    $-0.24
  • 52 Week High: $12.99
  • 52 Week Low: $6.22
  • Currency: US Dollars
  • Shares Issued: 23.47m
  • Volume: 4,643,002
  • Market Cap: $200.11m
  • RiskGrade: 720
  • Beta: 0.01

Novavax Inc. Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Novavax Inc. Fundamentals

Fundamentals data is not available for this company.

Novavax Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 478.23 (64.95) (38.60)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 250.42 (57.01) (38.55)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Novavax Inc. ShareCast News

US close: Stocks slide on automotive tariff conc... 27-Mar-2025 ShareCast
Novavax signs $1.2bn Covid-19 licensing deal wit... 10-May-2024 ShareCast
Novavax to cut global workforce by a quarter 09-May-2023 ShareCast

Novavax Inc. Top Newspaper Links

Local Digest 10-May-2009 Washington Post
Novavax Moves Closer to Licensing Bird Flu Vaccine 27-Aug-2008 Washington Post
Business Briefing 09-Aug-2008 Washington Post

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Novavax Inc. Market Data

Currency US Dollars
Share Price $ 8.53
Change Today $ -0.24
% Change -2.68 %
52 Week High $12.99
52 Week Low $6.22
Volume 4,643,002
Shares Issued 23.47m
Market Cap $200.11m
Beta 0.01
RiskGrade 720

What The Brokers Say

Strong Buy 2
Buy 3
Neutral 1
Sell 2
Strong Sell 1
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Nov-2026

Time Volume / Share Price
15:59 142 @ $8.53
15:59 285 @ $8.53
15:59 700 @ $8.53
15:59 400 @ $8.53
15:59 1,000 @ $8.52

Top of Page